AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 7016781 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 7016781 — intervention group
Group type: EXPERIMENTAL
Intervention: BAY g 5421
Number of subjects: 6
Study 31714598 — intervention group
Group type: EXPERIMENTAL
Intervention: Technology-based information and coaching/support program
Number of subjects: 115
Study 31714598 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 115
Study 31861457 — intervention group
Group type: EXPERIMENTAL
Intervention: Ophthalmologists
Number of subjects: 16
Study 31861457 — intervention group
Group type: COMPARATOR
Intervention: Optometrists
Number of subjects: 16
Study 28329381 — intervention group
Group type: EXPERIMENTAL
Intervention: 90‐minute nap opportunity
Number of subjects: 95
Study 28329381 — intervention group
Group type: COMPARATOR
Intervention: Quiet wakefulness interval
Number of subjects: 95
Study 25666740 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual misoprostol (400 µg)
Number of subjects: 100
Study 25666740 — intervention group
Group type: COMPARATOR
Intervention: Intravenous oxytocin (10 IU)
Number of subjects: 100
Study 24506332 — intervention group
Group type: EXPERIMENTAL
Intervention: High cognitive load with Black patient vignette
Number of subjects: 98
Study 24506332 — intervention group
Group type: EXPERIMENTAL
Intervention: Low cognitive load with Black patient vignette
Number of subjects: 98
Study 20712446 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical guide design (no guide, tube, channel, guided)
Number of subjects: 21
Study 20712446 — intervention group
Group type: EXPERIMENTAL
Intervention: Experienced surgeons
Number of subjects: 21
Study 20712446 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical guide design
Number of subjects: 21
Study 20712446 — intervention group
Group type: EXPERIMENTAL
Intervention: Size of edentulous sites
Number of subjects: 21
Study 19626807 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine for skin preparation (group 2)
Number of subjects: 500
Study 19626807 — intervention group
Group type: COMPARATOR
Intervention: Povidone Iodine for skin preparation (group 1)
Number of subjects: 500
Study 17312207 — intervention group
Group type: EXPERIMENTAL
Intervention: bupivacaine 3 mg + fentanyl 20 mug
Number of subjects: 100
Study 17312207 — intervention group
Group type: EXPERIMENTAL
Intervention: bupivacaine 7.5 mg
Number of subjects: 100
Study 17312207 — intervention group
Group type: EXPERIMENTAL
Intervention: bupivacaine 5 mg + fentanyl 20 mug
Number of subjects: 100
Study 17312207 — intervention group
Group type: EXPERIMENTAL
Intervention: bupivacaine 4 mg + fentanyl 20 mug
Number of subjects: 100
Study 14985992 — intervention group
Group type: EXPERIMENTAL
Intervention: Nocturnal trapezius muscle activity
Number of subjects: 60
Study 14985992 — intervention group
Group type: EXPERIMENTAL
Intervention: Deltoid muscle activity
Number of subjects: 60
Study 14985992 — intervention group
Group type: EXPERIMENTAL
Intervention: Biceps and hand flexors muscle activity
Number of subjects: 60
Study 14985992 — intervention group
Group type: EXPERIMENTAL
Intervention: Nocturnal trapezius activity
Number of subjects: 60
Study 12479490 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality improvement intervention for depression treatment
Number of subjects: 938
Study 12479490 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 938
Study 15468432 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular ISG (4 mL every 2 months from unscreened donors)
Number of subjects: 899
Study 15468432 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 899
Study 7656524 — intervention group
Group type: EXPERIMENTAL
Intervention: Air as an insufflation agent
Number of subjects: 100
Study 7656524 — intervention group
Group type: COMPARATOR
Intervention: CO2 as an insufflation agent
Number of subjects: 100
Study 2523493 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone (CTRX) 1 g once daily
Number of subjects: 0
Study 2523493 — intervention group
Group type: COMPARATOR
Intervention: Cefotiam (CTM) 2 g twice daily
Number of subjects: 0
Study 791457 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextran 40
Number of subjects: 0
Study 31480062 — intervention group
Group type: EXPERIMENTAL
Intervention: DOACs
Number of subjects: 41
Study 31480062 — intervention group
Group type: COMPARATOR
Intervention: VKAs
Number of subjects: 41
Study 28569122 — intervention group
Group type: EXPERIMENTAL
Intervention: Fingolimod combined with bridging therapy (Alteplase and Mechanical Thrombectomy)
Number of subjects: 98
Study 28569122 — intervention group
Group type: COMPARATOR
Intervention: Bridging therapy (Alteplase and Mechanical Thrombectomy) alone
Number of subjects: 98
Study 28569122 — intervention group
Group type: EXPERIMENTAL
Intervention: Fingolimod combined with bridging therapy
Number of subjects: 98
Study 25495748 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated Risk Reduction Intervention (IRRI)
Number of subjects: 122
Study 25495748 — intervention group
Group type: COMPARATOR
Intervention: Psychiatric care with medical monitoring (Control)
Number of subjects: 122
Study 23784896 — intervention group
Group type: EXPERIMENTAL
Intervention: Professional health coach
Number of subjects: 44
Study 23784896 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer health coach
Number of subjects: 44
Study 23784896 — intervention group
Group type: EXPERIMENTAL
Intervention: Mentor health coach
Number of subjects: 44
Study 21131132 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) treatment
Number of subjects: 28
Study 21131132 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 28
Study 20027436 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% carbamide peroxide
Number of subjects: 10
Study 20027436 — intervention group
Group type: EXPERIMENTAL
Intervention: 7.5% hydrogen peroxide
Number of subjects: 10
Study 20027436 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 10
Study 17522018 — intervention group
Group type: EXPERIMENTAL
Intervention: First acquired memory with a reminder presented 5 min before the second training
Number of subjects: 0
Study 17522018 — intervention group
Group type: EXPERIMENTAL
Intervention: Second training given 5 min instead of 24 h after the first training
Number of subjects: 0
Study 17522018 — intervention group
Group type: EXPERIMENTAL
Intervention: First retrieval
Number of subjects: 0
Study 17522018 — intervention group
Group type: EXPERIMENTAL
Intervention: Absence of RIF effect
Number of subjects: 0
Study 15249265 — intervention group
Group type: EXPERIMENTAL
Intervention: Visualization Group (standardized information supported by a tool for displaying two-dimensional pictures and informative leaflet)
Number of subjects: 56
Study 15249265 — intervention group
Group type: COMPARATOR
Intervention: Control Group (standardized information and informative leaflet only)
Number of subjects: 56
Study 15249265 — intervention group
Group type: EXPERIMENTAL
Intervention: Visualization Group
Number of subjects: 56
Study 15249265 — intervention group
Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 56
Study 15259389 — intervention group
Group type: EXPERIMENTAL
Intervention: APOE epsilon4 allele
Number of subjects: 0
Study 15259389 — intervention group
Group type: EXPERIMENTAL
Intervention: Below average memory with APOE epsilon4 allele
Number of subjects: 0
Study 15259389 — intervention group
Group type: EXPERIMENTAL
Intervention: Below average memory without APOE epsilon4 allele
Number of subjects: 0
Study 15259389 — intervention group
Group type: COMPARATOR
Intervention: Average or better memory with APOE epsilon4 allele
Number of subjects: 0
Study 9871428 — intervention group
Group type: EXPERIMENTAL
Intervention: GI198745 (0.1 to 40 mg)
Number of subjects: 48
Study 9871428 — intervention group
Group type: EXPERIMENTAL
Intervention: Finasteride (5 mg)
Number of subjects: 48
Study 9871428 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 7658281 — intervention group
Group type: EXPERIMENTAL
Intervention: Amino acids (1.15 +/- 0.06 gm.kg‐1.day‐1) and glucose (6.05 +/- 1.58 gm.kg‐1.day‐1)
Number of subjects: 18
Study 7658281 — intervention group
Group type: COMPARATOR
Intervention: Glucose (6.48 +/- 1.30 gm.kg‐1.day‐1)
Number of subjects: 18
Study 2696429 — intervention group
Group type: EXPERIMENTAL
Intervention: Povidone iodine (PVI)
Number of subjects: 0
Study 2696429 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine (CHX)
Number of subjects: 0
Study 2696429 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonmedicated soap (NMS)
Number of subjects: 0
Study 325726 — intervention group
Group type: EXPERIMENTAL
Intervention: High doses of steroid drugs
Number of subjects: 36
Study 325726 — intervention group
Group type: COMPARATOR
Intervention: High doses of steroid drugs + 600 rads of radiotherapy to the graft
Number of subjects: 36
Study 30759457 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal valve lift treatment using absorbable, polylactic acid, self‐retaining cone threads (Silhouette Soft)
Number of subjects: 60
Study 30759457 — intervention group
Group type: COMPARATOR
Intervention: Nasal valve lift treatment using absorbable, polylactic acid, self‐retaining cone threads (Silhouette Soft) + turbinoplasty
Number of subjects: 60
Study 27531752 — intervention group
Group type: EXPERIMENTAL
Intervention: Cal/BD foam
Number of subjects: 463
Study 27531752 — intervention group
Group type: COMPARATOR
Intervention: Cal/BD gel
Number of subjects: 463
Study 26283990 — intervention group
Group type: EXPERIMENTAL
Intervention: Metacognition-augmented cognitive remediation (CR)
Number of subjects: 90
Study 26283990 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard cognitive remediation (mybraintraining)
Number of subjects: 90
Study 26283990 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 90
Study 25715721 — intervention group
Group type: EXPERIMENTAL
Intervention: Haas expander
Number of subjects: 31
Study 25715721 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyrax expander
Number of subjects: 31
Study 21497444 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg cortisol
Number of subjects: 0
Study 21497444 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 19032566 — intervention group
Group type: EXPERIMENTAL
Intervention: Colloid boluses of 200 ml until stroke volume did not increase >or=10%
Number of subjects: 20
Study 19032566 — intervention group
Group type: EXPERIMENTAL
Intervention: Stroke volume measured beat to beat
Number of subjects: 20
Study 19032566 — intervention group
Group type: EXPERIMENTAL
Intervention: Stroke volume averaged over 10 heartbeats
Number of subjects: 20
Study 17366758 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2% ZnCl2 toothpaste
Number of subjects: 20
Study 17366758 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.66% AmF toothpaste
Number of subjects: 20
Study 17366758 — intervention group
Group type: COMPARATOR
Intervention: Both toothpastes
Number of subjects: 20
Study 15016643 — intervention group
Group type: COMPARATOR
Intervention: CHOP‐21 (standard chemotherapy every 3 weeks)
Number of subjects: 689
Study 15016643 — intervention group
Group type: COMPARATOR
Intervention: CHOEP‐21 (CHOP plus etoposide 100 mg/m2 days 1‐3)
Number of subjects: 689
Study 15016643 — intervention group
Group type: EXPERIMENTAL
Intervention: CHOP‐14 (biweekly chemotherapy)
Number of subjects: 689
Study 15016643 — intervention group
Group type: EXPERIMENTAL
Intervention: CHOEP‐14 (biweekly CHOP plus etoposide)
Number of subjects: 689
Study 11757689 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple eradication therapy (Clarithromycin 500 mg/d, Metronidazol 800 mg/d, Omeprazol 40 mg/d for 7 days)
Number of subjects: 2
Study 9439537 — intervention group
Group type: EXPERIMENTAL
Intervention: T3 treatment
Number of subjects: 7
Study 7907083 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitroglycerin
Number of subjects: 0
Study 7907083 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolazoline
Number of subjects: 0
Study 7907083 — intervention group
Group type: EXPERIMENTAL
Intervention: Buflomedyl
Number of subjects: 0
Study 7907083 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 2890668 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevantolol (HCl salt) after an overnight fast
Number of subjects: 12
Study 2890668 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevantolol (HCl salt) 15 minutes before breakfast
Number of subjects: 12
Study 2890668 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevantolol (HCl salt) 15 minutes after breakfast
Number of subjects: 12
Study 2890668 — intervention group
Group type: COMPARATOR
Intervention: Bevantolol (HCl salt) after breakfast
Number of subjects: 12
Study 29185480 — intervention group
Group type: EXPERIMENTAL
Intervention: JNJ‐39393406 (100 mg b.i.d.)
Number of subjects: 98
Study 29185480 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 98
Study 27113448 — intervention group
Group type: EXPERIMENTAL
Intervention: Face to face tobacco cessation counseling session
Number of subjects: 39
Study 27113448 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 39
Study 24423155 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg/day TTP488
Number of subjects: 399
Study 24423155 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg/day TTP488
Number of subjects: 399
Study 24423155 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 399
Study 24423155 — intervention group
Group type: EXPERIMENTAL
Intervention: TTP488 plasma concentrations (7.6-16.8 ng/mL)
Number of subjects: 399
Study 24423155 — intervention group
Group type: EXPERIMENTAL
Intervention: TTP488 plasma concentrations (46.8-167.0 ng/mL)
Number of subjects: 399
Study 22188544 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel hydrogen sulfate (CHS) 600 mg loading dose followed by 75 mg/day
Number of subjects: 96
Study 22188544 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel besylate (CB) 600 mg loading dose followed by 75 mg/day
Number of subjects: 96
Study 20159820 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-year aerobic exercise intervention of 225 min/wk (n = 160)
Number of subjects: 320
Study 20159820 — intervention group
Group type: COMPARATOR
Intervention: Control group maintaining usual level of activity (n = 160)
Number of subjects: 320
Study 17485382 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced intensity allogeneic stem cell transplantation (SCT) with lower intensity conditioning regimens.
Number of subjects: 0
Study 17485382 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermediate intensity, non‐myeloablative conditioning regimens.
Number of subjects: 0
Study 17485382 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous transplant performed just prior to allografting.
Number of subjects: 0
Study 17485382 — intervention group
Group type: EXPERIMENTAL
Intervention: Peripheral blood cells and graft engineering to improve graft versus myeloma activity.
Number of subjects: 0
Study 17485382 — intervention group
Group type: EXPERIMENTAL
Intervention: Post transplant maintenance and targeted conditioning therapies such as bone seeking radioisotopes.
Number of subjects: 0
Study 16130862 — intervention group
Group type: EXPERIMENTAL
Intervention: Micro Prime
Number of subjects: 60
Study 16130862 — intervention group
Group type: EXPERIMENTAL
Intervention: Gluma Desensitizer
Number of subjects: 60
Study 16130862 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervitec
Number of subjects: 60
Study 16130862 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 60
Study 11867179 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 44
Study 11867179 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 11867179 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol in HVPG responders
Number of subjects: 44
Study 11867179 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol in HVPG non-responders
Number of subjects: 44
Study 11867179 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol in responders
Number of subjects: 44
Study 11867179 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol in non-responders
Number of subjects: 44
Study 10560446 — intervention group
Group type: EXPERIMENTAL
Intervention: Referral to specialists who enroll patients in clinical trials
Number of subjects: 85
Study 10560446 — intervention group
Group type: EXPERIMENTAL
Intervention: Belief in clinical trials increasing knowledge about treatment options
Number of subjects: 85
Study 10560446 — intervention group
Group type: EXPERIMENTAL
Intervention: Perception of randomised trials making a valuable scientific contribution
Number of subjects: 85
Study 10560446 — intervention group
Group type: EXPERIMENTAL
Intervention: Concerns about patient disadvantage in clinical trials
Number of subjects: 85
Study 10560446 — intervention group
Group type: EXPERIMENTAL
Intervention: Desire for optimum treatment for patients
Number of subjects: 85
Study 10560446 — intervention group
Group type: EXPERIMENTAL
Intervention: Desire to know about the trial
Number of subjects: 85
Study 10560446 — intervention group
Group type: EXPERIMENTAL
Intervention: Concerns about ethical considerations
Number of subjects: 85
Study 7555486 — intervention group
Group type: EXPERIMENTAL
Intervention: High-carbohydrate low-fat (HCLF) diet
Number of subjects: 24
Study 7555486 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified-fat (MF) diet
Number of subjects: 24
Study 7555486 — intervention group
Group type: COMPARATOR
Intervention: Control (baseline)
Number of subjects: 24
Study 1552208 — intervention group
Group type: EXPERIMENTAL
Intervention: Natural human leukocyte interferon-alpha (IFN-alpha n3)
Number of subjects: 0
Study 1552208 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 3552010 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazemuls (0.15 mg kg‐1)
Number of subjects: 0
Study 3552010 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam (0.07 mg kg‐1)
Number of subjects: 0
Study 3552010 — intervention group
Group type: COMPARATOR
Intervention: Control (normal liver function)
Number of subjects: 0
Study 31646475 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized dexamethasone 8 mg 1 hour before surgery
Number of subjects: 80
Study 31646475 — intervention group
Group type: COMPARATOR
Intervention: Saline nebulizer (control group)
Number of subjects: 80
Study 29855840 — intervention group
Group type: EXPERIMENTAL
Intervention: MIHOW
Number of subjects: 188
Study 29855840 — intervention group
Group type: COMPARATOR
Intervention: MEI
Number of subjects: 188
Study 27385652 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise + diet management
Number of subjects: 36
Study 27385652 — intervention group
Group type: COMPARATOR
Intervention: Diet alone
Number of subjects: 36
Study 25943532 — intervention group
Group type: EXPERIMENTAL
Intervention: APC8015F
Number of subjects: 249
Study 25943532 — intervention group
Group type: COMPARATOR
Intervention: sipuleucel-T
Number of subjects: 249
Study 23958323 — intervention group
Group type: EXPERIMENTAL
Intervention: Porous silk fibroin scaffolds decorated with RGD sequences (SF-RGD) seeded with human mesenchymal stem cells (hMSC)
Number of subjects: 8
Study 21614684 — intervention group
Group type: EXPERIMENTAL
Intervention: CAR27 device
Number of subjects: 60
Study 21614684 — intervention group
Group type: COMPARATOR
Intervention: Traditional stapling device
Number of subjects: 60
Study 18496110 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-assisted learning (CAL)
Number of subjects: 23
Study 18496110 — intervention group
Group type: COMPARATOR
Intervention: Nonintervention group
Number of subjects: 23
Study 16800343 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy using Cisplatin and Etoposide along with Wobe Mugos E
Number of subjects: 40
Study 16800343 — intervention group
Group type: COMPARATOR
Intervention: Neoadjuvant chemotherapy using Cisplatin and Etoposide
Number of subjects: 40
Study 14615732 — intervention group
Group type: EXPERIMENTAL
Intervention: ReSoMaL
Number of subjects: 130
Study 14615732 — intervention group
Group type: COMPARATOR
Intervention: WHO‐ORS
Number of subjects: 130
Study 10925060 — intervention group
Group type: EXPERIMENTAL
Intervention: E/I ratio
Number of subjects: 372
Study 10925060 — intervention group
Group type: EXPERIMENTAL
Intervention: Valsalva
Number of subjects: 372
Study 10925060 — intervention group
Group type: EXPERIMENTAL
Intervention: 30:15 ratio
Number of subjects: 372
Study 10925060 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained Handgrip
Number of subjects: 372
Study 10925060 — intervention group
Group type: EXPERIMENTAL
Intervention: Orthostatic BP
Number of subjects: 372
Study 10925060 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of two sympathetic tests
Number of subjects: 372
Study 10925060 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of all five tests
Number of subjects: 372
Study 7799046 — intervention group
Group type: EXPERIMENTAL
Intervention: rhGM‐CSF
Number of subjects: 104
Study 2129634 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-lactose, low-fat feed (HN25)
Number of subjects: 60
Study 2129634 — intervention group
Group type: COMPARATOR
Intervention: Conventional formula (SMA)
Number of subjects: 60
Study 2129634 — intervention group
Group type: COMPARATOR
Intervention: Hydrolysed soya and collagen feed (Prejomin)
Number of subjects: 60
Study 6105118 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 g daily sulphasalazine
Number of subjects: 170
Study 6105118 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 g daily sulphasalazine
Number of subjects: 170
Study 6105118 — intervention group
Group type: COMPARATOR
Intervention: 1 g daily sulphasalazine
Number of subjects: 170
Study 30008106 — intervention group
Group type: EXPERIMENTAL
Intervention: High-protein nutrient preload (50-g Parmesan cheese, one boiled egg, and 300-ml water)
Number of subjects: 16
Study 30008106 — intervention group
Group type: COMPARATOR
Intervention: Water (500-ml)
Number of subjects: 16
Study 30008106 — intervention group
Group type: EXPERIMENTAL
Intervention: High-protein nutrient preload
Number of subjects: 16
Study 28137487 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training (IMT)
Number of subjects: 29
Study 28137487 — intervention group
Group type: COMPARATOR
Intervention: Sham training
Number of subjects: 29
Study 26067942 — intervention group
Group type: EXPERIMENTAL
Intervention: Photon-Induced Photoacoustic Streaming (PIPS)
Number of subjects: 24
Study 26067942 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonic irrigation
Number of subjects: 24